Fluoxetine for Motor, Aphasia, and Neglect Recovery After Ischemic Stroke (FLAN)

Pilot RCT of Fluoxetine vs Placebo to Treat Motor, Language and Unilateral Neglect After Ischemic Stroke

This pilot study will recruit 25 subjects to assess the feasibility of replicating the FLAME study (Chollet, et al. Lancet 2011), a randomized controlled trial (RCT) that assessed the effect of fluoxetine vs placebo on motor recovery after ischemic stroke, in an American sample of post-acute stroke patients. This trial will in addition examine the effect of treatment with fluoxetine versus placebo on concurrent deficits in language and hemispatial attention, as well as post-stroke fatigue and will evaluate the durability of observed effects. The results of this pilot trial will be used to develop power estimates for a larger trial and to evaluate recruitment and intervention completion rates for subjects in an American post-acute environment. There are two additional substudies: the first will use MRI to assess structural changes at the beginning and end of the intervention; the second will examine the relationship of serum biomarkers of inflammation to the intervention.

Inclusion Criteria: Ischemic infarction within 15 days Admission NIHSS item 5 score equal to or >2 -Able to give informed consent, with surrogate consent acceptable- Exclusion Criteria: Pre-stroke modified Rankin Scale score equal or .3 Pregnant or lactating Taking an SSRI on admission to SRH Taking a medication likely to have adverse interaction with an SSRI Unable to return for follow-up testing days 90,180 Concurrent medial condition likely to worsen patient's functional status over next 6 months Unable to competently participate in testing for 45min-2hrs with rest breaks for MRI substudy: contraindication to MRI